JeremyKHonMD

Oncology • Huntsville, AL

Hematologic Oncology

Director, stem cell transplant program Huntsville hospital

Join to view full profile

Dr. Hon is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Hon's full profile

Already have an account?

Office
3601 Cci Dr Nw
Huntsville, AL 35805
Phone+1 256-705-4224

Fax+1 256-327-8982
Is this information wrong?

Summary

Dr. Jeremy Hon is an oncologist in Huntsville, AL and was affiliated with multiple hospitals in the area, including Crestwood Medical Center and Huntsville Hospital.He received his medical degree from University of Alabama School of Medicine and has been in practice 41 years. He is experienced in hematology medical oncology and autologous stem cell transplant. He recently retired from his practice at clearview cancer institute in huntsville, Alabama. He is currently residing overseas in an area relatively safe from COVID-19

Education & Training

University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineFellowship, Hematology and Medical Oncology, 1983 - 1985
University of Texas Health Science Center at HoustonResidency, Internal Medicine, 1980 - 1983
University of Alabama School of MedicineClass of 1980

Certifications & Licensure

AL State Medical License 1985 - 2021
TN State Medical License 1990 - 1994
TX State Medical License 1981 - 1993

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification OncoEMR, Altos Solutions, Inc., 2012-2013

Publications & Presentations

PubMed

25 citations
Patient-reported neuropathy and taxane-associated symptoms in a phase 3 trial of nab-paclitaxel plus carboplatin versus solvent-based paclitaxel plus carboplatin for a...
Vera Hirsh, Isamu Okamoto, Jeremy K. Hon, Ray D. Page, J. Orsini, Hiroshi Sakai, Hui Zhang, Markus F. Renschler, Mark A. Socinski> ;Journal of Thoracic Oncology. 2014 Jan 1
53 citations
Safety and efficacy analysis by histology of weekly nab-paclitaxel in combination with carboplatin as first-line therapy in patients with advanced non-small-cell lung ...
Mark A. Socinski, Isamu Okamoto, Jeremy K. Hon, Vera Hirsh, Shaker R. Dakhil, Ray D. Page, J. Orsini, N. Yamamoto, Hui Zhang, Markus F. Renschler> ;Annals of Oncology. 2013 Sep 1
Safety and efficacy of weekly nab®-paclitaxel in combination with carboplatin as first-line therapy in elderly patients with advanced non-small-cell lung cancer.
Socinski MA, Langer CJ, Okamoto I, Hon JK, Hirsh V, Dakhil SR, Page RD, Orsini J, Zhang H, Renschler MF> ;Ann. Oncol.. 2013-02-01
546 citations
Weekly nab-Paclitaxel in Combination With Carboplatin Versus Solvent-Based Paclitaxel Plus Carboplatin as First-Line Therapy in Patients With Advanced Non–Small-Cell L...
Mark A. Socinski, Igor Bondarenko, Nina Karaseva, Anatoly M. Makhson, Igor Vynnychenko, Isamu Okamoto, Jeremy K. Hon, Vera Hirsh, P. Bhar, Hui Zhang, Jose Iglesias, Ma...> ;Journal of Clinical Oncology. 2012 Jun 10
Survival results of a randomized, phase III trial of nab-paclitaxel and carboplatin compared with cremophor-based paclitaxel and carboplatin as first-line therapy in a...
Socinski MA, Bondarenko IN, Karaseva NA, Makhson A, Vynnychenko I, Okamoto I, Hon JK, Hirsh V, Bhar P, Berk GI, Iglesias JL> ;J. Clin. Oncol.. 2011-05-20
Results of a randomized, phase III trial of nab-paclitaxel (nab-P) and carboplatin (C) compared with cremophor-based paclitaxel (P) and carboplatin as first-line thera...
Socinski MA, Bondarenko IN, Karaseva NA, Makhson A, Vynnichenko I, Okamoto I, Hon JK, Hirsh V, Bhar P, Iglesias J> ;J. Clin. Oncol.. 2010-06-20
30 citations
Weekly treatment with bortezomib for patients with recurrent or refractory multiple myeloma: a phase 2 trial of the Minnie Pearl Cancer Research Network.
John D. Hainsworth, David R. Spigel, J. H. Barton, C. Farley, Marshall T. Schreeder, Jeremy K. Hon, F. Anthony Greco> ;Cancer. 2008 Aug 15
7 citations
Community-based phase II trial of pentostatin, cyclophosphamide, and rituximab (PCR) biochemotherapy in chronic lymphocytic leukemia and small lymphocytic lymphoma.
Robert O. Dillman, Marshall T. Schreeder, Jeremy K. Hon, Elizabeth F. Connelly, Carol DePriest, Kathy Cutter> ;Cancer Biotherapy & Radiopharmaceuticals. 2007 Jun 28
Paclitaxel/carboplatin/etoposide (PCE) therapy for advanced poorly differentiated neuroendocrine (PDNE) carcinoma: A Minnie Pearl Cancer Research Network phase II trial.
Miranda FT, Spigel DR, Hainsworth JD, Thompson DS, Yardley DA, Burris HA, Litchy S, Shrader M, Hon JK, Corso SW, Greco FA> ;J. Clin. Oncol.. 2005-06-01
Community-based trial of pentostatin, cyclophosphamide, and rituximab (PCR) in chronic lymphocytic leukemia (CLL) and small B-cell lymphocytic lymphoma (SLL).
Dillman RO, Schreeder MT, Hon JK, Depriest C, Kennedy PS, Green RJ> ;J. Clin. Oncol.. 2005-06-01
Long-term follow-up of limited stage small cell lung cancer patients treated with carboplatin-based chemotherapy and radiotherapy by the Minnie Pearl Cancer Research N...
Spigel DR, Hainsworth JD, Burris HA, Dannaher C, Hon J, Morrissey LH, Greco FA> ;J. Clin. Oncol.. 2004-07-15
Carcinoma of unknown primary site with unfavorable characteristics: Survival of 396 patients after treatment with five consecutive phase II trials by the Minnie Pearl ...
Greco FA, Litchy S, Dannaher C, Hermann RC, Pati A, Hon J, Thompson DS, Hainsworth JD> ;J. Clin. Oncol.. 2004-07-15
7 citations
Long-Term Follow-Up of Patients Treated With Paclitaxel/Carboplatin-Based Chemotherapy for Advanced Non–Small-Cell Lung Cancer: Sequential Phase II Trials of the Minni...
John D. Hainsworth, J. R. Gray, Lisa H. Morrissey, L A Kalman, Jeremy K. Hon, F. Anthony Greco> ;Journal of Clinical Oncology. 2002 Jul 1
35 citations
Gemcitabine and vinorelbine in the second-line treatment of nonsmall cell lung carcinoma patients: a minnie pearl cancer research network phase II trial.
John D. Hainsworth, Howard A. Burris, Sharlene Litchy, Joan B. Erland, Jeremy K. Hon, Joseph E. Brierre, F. Anthony Greco> ;Cancer. 2000 Mar 15
36 citations
Phase I/II trial of paclitaxel by 1-hour infusion, carboplatin, and gemcitabine in the treatment of patients with advanced nonsmall cell lung carcinoma.
John D. Hainsworth, Howard A. Burris, Joan B. Erland, Lisa H. Morrissey, A. A. Meluch, L A Kalman, Jeremy K. Hon, Daniel C. Scullin, Steven W. Smith, F. Anthony Greco> ;Cancer. 1999 Mar 15
8 citations
Rapid in vitro assay for predicting response to fluorouracil in patients with metastatic breast cancer.
Richard M. Elledge, Gary M. Clark, Jeremy K. Hon, M. Thant, R. J. Belt, Y P Maguire, J Brown, P Bartels, D. D. Von Hoff> ;Journal of Clinical Oncology. 1995 Feb 1
Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trials.
Major, P., Lortholary, A., Hon, J., Abdi, E., Mills, G., Menssen, H. D., Yunus, F., Bell, R., Body, J., Quebe-Fehling, E., Seaman, J.> ;J Clin Oncol. 2001 Jan 15
Mucormycosis: a community hospital perspective.
Harris, L. F., Hon, J. K., Schreeder, M. T.> ;Ala Med. 1990 Jul 01
One-hour paclitaxel plus carboplatin in the treatment of advanced non-small cell lung cancer: results of a multicentre, phase II trial.
Hainsworth, J. D., Urba, W. J., Hon, J. K., Thompson, K. A., Stagg, M. P., Hopkins, L. G., Thomas, M., Greco, F. A.> ;Eur J Cancer. 1998 Apr
Phase II trial evaluating triplet chemotherapy using gemcitabine, paclitaxel, and carboplatin in the treatment of patients with advanced non-small cell lung cancer.
Burris, H. A., Hainsworth, J. D., Erland, J. B., Morrissey, L. H., Kalman, L. A., Hon, J. K., Scullin, D. C., Smith, S. W., Greco, F. A.> ;Semin Oncol. 2000 Feb
Join now to see all

Professional Memberships

American College of Physicians - ACP
Member
American Society of Clinical Oncology - ASCO
Member

Hospital Affiliations

Crestwood Medical CenterHuntsville, Alabama
Huntsville HospitalHuntsville, Alabama
Decatur Morgan HospitalDecatur, Alabama